https://medicine.ouhsc.edu/directory Parent Page: Directory id: 22535 Active Page: Detailsid:23325

Directory

Categories

Emily A. Siegrist, PharmD, BCIDP
Internal Medicine

Emily A. Siegrist, PharmD, BCIDP

Clinical Instructor (Volunteer Faculty)
Infectious Diseases Clinical PHarmacist, OU Health


700 NE 13th St.
Oklahoma City, OK  73104

405-271-8000 x33392

emily.siegrist@ouhealth.com


Academic Section(s):

Infectious Diseases


Education:

2014 - 2018     Doctor of Pharmacy
                         University of Texas, Austin, TX


Board Certification(s):

Board Certified Infectious Diseases Pharmacist (BCIDP)


Residency:

2018 - 2019     Pharmacy Resident
                         Intermountain Medical Center, Intermountain
                         Healthcare, Murray, UT

2019 - 2020     Infectious Diseases Pharmacy Resident
                         Maine Medical Center, Mainehealth, Portland, ME


Select Publications:

Siegrist, E. A., Sassine, J. (2022). Antivirals with Activity Against Monkeypox: A Clinically Oriented Review. Clinical Infectious Diseases. PMID: 35904001. DOI: 10.1093/cid/ciac622

Siegrist, E. A., Sassine, J. (2022). Shorter might not always be better: the case for longer antibiotic therapy for Pseudomonas aeruginosa pneumonia.  Intensive Care Medicine, 48(7), 963-964. PMID:35616656. DOI: https://doi.org/10.1007/s00134-022-06754-6.

White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21(9):1208-1209. doi:10.1016/S1473-3099(21)00456-4.

Siegrist EA, Wungwattana M, Azis L, et al. Limited clinical utility of follow-up blood cultures in patients with streptococcal bacteremia: An opportunity for blood culture stewardship. Open Forum Infectious Disease. 2020;7(12).

Leal J, Dong T, Taylor A, Siegrist EA, Gao F, Smyth HDC, Ghosh D. Mucus-penetrating phage-displayed peptides for improved transport across a mucus-like model. Int J Pharmaceutics. 2018;553(1-2):57-64.